Tanshinone IIA Modulates Low Density Lipoprotein Uptake via Down-Regulation of PCSK9 Gene Expression in HepG2 Cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tanshinone IIA Modulates Low Density Lipoprotein Uptake via Down-Regulation of PCSK9 Gene Expression in HepG2 Cells
Authors
Keywords
Gene expression, Cholesterol, Statins, Transcription factors, Transcriptional control, Luciferase, Flow cytometry, Plasmid construction
Journal
PLoS One
Volume 11, Issue 9, Pages e0162414
Publisher
Public Library of Science (PLoS)
Online
2016-09-13
DOI
10.1371/journal.pone.0162414
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Approach to Statin Use in 2016: an Update
- (2016) P. Elliott Miller et al. Current Atherosclerosis Reports
- Role of Ezetimibe in Lipid-Lowering and Cardiovascular Disease Prevention
- (2015) Bryan A. Smith et al. Current Atherosclerosis Reports
- Clinical Efficacy and Safety of Ezetimibe on Major Cardiovascular Endpoints: Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2015) Alessandro Battaggia et al. PLoS One
- PCSK9 and LDLR degradation
- (2014) Thomas A. Lagace CURRENT OPINION IN LIPIDOLOGY
- Anti-Inflammatory and Immunomodulatory Mechanism of Tanshinone IIA for Atherosclerosis
- (2014) Zhuo Chen et al. Evidence-based Complementary and Alternative Medicine
- Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells
- (2014) Mi-Hsueh Tai et al. MOLECULAR NUTRITION & FOOD RESEARCH
- A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
- (2014) Dirk J. Blom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential of Proprotein Convertase Subtilisin/Kexin Type 9 Based Therapeutics
- (2013) Evan A. Stein et al. Current Atherosclerosis Reports
- FoxO3 Transcription Factor and Sirt6 Deacetylase Regulate Low Density Lipoprotein (LDL)-cholesterol Homeostasis via Control of the Proprotein Convertase Subtilisin/Kexin Type 9 (Pcsk9) Gene Expression
- (2013) Rongya Tao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6
- (2013) Rongya Tao et al. JOURNAL OF LIPID RESEARCH
- Tanshinone IIA suppresses cholesterol accumulation in human macrophages: role of heme oxygenase-1
- (2013) Zhiping Liu et al. JOURNAL OF LIPID RESEARCH
- Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
- (2013) Kevin Fitzgerald et al. LANCET
- Down-Regulation of the Oncogene PTTG1 via the KLF6 Tumor Suppressor during Induction of Myeloid Differentiation
- (2013) Pei-Yi Chen et al. PLoS One
- Tanshinone IIA: A Promising Natural Cardioprotective Agent
- (2012) Qinghua Shang et al. Evidence-based Complementary and Alternative Medicine
- Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation
- (2012) Suowen Xu et al. Translational Research
- Clinical aspects of PCSK9
- (2011) Bertrand Cariou et al. ATHEROSCLEROSIS
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress
- (2011) Wenying Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Managing the underestimated risk of statin-associated myopathy
- (2011) Loukianos S. Rallidis et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Citrus flavonoid 5-demethylnobiletin suppresses scavenger receptor expression in THP-1 cells and alters lipid homeostasis in HepG2 liver cells
- (2011) Jui-Hung Yen et al. MOLECULAR NUTRITION & FOOD RESEARCH
- The Extending Network of FOXO Transcriptional Target Genes
- (2010) Kristan E. van der Vos et al. ANTIOXIDANTS & REDOX SIGNALING
- Heart Disease and Stroke Statistics—2011 Update
- (2010) Véronique L. Roger et al. CIRCULATION
- β1-Integrin-Collagen Interaction Suppresses FoxO3a by the Coordination of Akt and PP2A
- (2010) Richard Seonghun Nho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?
- (2010) Steven J. R. Meex et al. JOURNAL OF LIPID RESEARCH
- Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters
- (2010) Bin Dong et al. JOURNAL OF LIPID RESEARCH
- The LDL Receptor
- (2009) Joseph L. Goldstein et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Inhibition of PCSK9 as a novel strategy for the treatment of hypercholesterolemia
- (2009) D. Lopez DRUG NEWS & PERSPECTIVES
- Hepatocyte Nuclear Factor 1α Plays a Critical Role inPCSK9Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
- (2009) Hai Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
- (2009) Noam Zelcer et al. SCIENCE
- PCSK9 and LDL cholesterol: unravelling the target to design the bullet
- (2008) Philippe Costet et al. TRENDS IN BIOCHEMICAL SCIENCES
- Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion
- (2007) Jing-Yan Han et al. PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now